GlassScriptPhysician profile
Thais Delgado
NPI 1538905963
$5,148.12
in general payments reported to CMS, 2019-2025
17 companies · $4,247 in 2025
The $4,247 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $97.88 · 2024: $803 · 2025: $4,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,980 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,980.13 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $927.69 | 2024-2025 | |
| Galderma Laboratories, L.P. | $919.26 | 2024-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $774.30 | 2025 | Zoryve |
| Janssen Biotech, INC. | $623.06 | 2024-2025 | Tremfya, Simponi Aria, Stelara |
| Sun Pharmaceutical Industries INC. | $519.54 | 2024-2025 | |
| Ucb, INC. | $323.62 | 2025 | Bimzelx |
| Pfizer INC. | $242.16 | 2023-2025 | |
| Genzyme Corporation | $199.39 | 2024-2025 | |
| Verrica Pharmaceuticals INC. | $147.94 | 2025 | Ycanth |
| E.R. Squibb & Sons, L.L.C. | $143.13 | 2025 | Sotyktu |
| Lilly USA, LLC | $117.41 | 2025 | Ebglyss, Taltz |
| Incyte Corporation | $52.23 | 2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $45.24 | 2025 | |
| Janssen Scientific Affairs, LLC | $41.94 | 2024 | Tremfya |
| Almirall LLC | $29.77 | 2025 | Seysara |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $24.07 | 2025 | Dupixent |
| Organon LLC | $17.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thais Delgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.